Faculty profile

Damien Gallagher

ResearcherPsychiatryUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Damien Gallagher

Researcher

Psychiatry

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
29 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Alzheimer'S Disease Angiogenesis Cognition Exercise Neuroplasticity Transcranial Direct Current Stimulation Alzheimer'S Dementia Depression

Latest papers

Angiogenesis markers and cognitive response in a randomized trial of cognitive remediation plus transcranial direct current stimulation in older adults at risk of dementia.
Journal of Alzheimer's disease : JAD · 2026
Feasibility of home testing to detect undiagnosed obstructive sleep apnea in late life depression.
Sleep medicine · 2026 · senior author
Three-order interactions in the alpha band of default mode network EEGs based on O-information rate: insights from aging and Alzheimer's disease.
Alzheimer's research & therapy · 2026

All 55 publications

Latest funding

Exercise augmenting cognition tDCS (EXACT) trial: A pilot study of a combined exercise and transcranial direct current stimulation intervention for cognition
CIHR · 2022 · Principal investigator
$456,706
Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training (PRIMiNG-AT)
CIHR · 2021 · Co-investigator
$747,439
Methylphenidate-primed rTMS for apathy in neurocognitive disorders
CIHR · 2021 · Co-investigator
$100,000

All 7 grants and awards

55 publications.

Angiogenesis markers and cognitive response in a randomized trial of cognitive remediation plus transcranial direct current stimulation in older adults at risk of dementia.

Song BX, Schecter J, Vieira E, Gallagher D, Diniz BS, Fischer CE, Flint AJ, Herrmann N, Kennedy JL, Mah L, Mulsant B, Pollock BG, Rajji TK, Ma C, Lanctôt KL, PACt-MD Study Group

Journal of Alzheimer's disease : JAD2026

DOI: 10.1177/13872877261457934 PMID: 42300721

Feasibility of home testing to detect undiagnosed obstructive sleep apnea in late life depression.

Singh R, Berger S, Siddiqui M, Rapoport M, Herrmann N, Lanctot KL, Boulos MI, Gallagher D

Sleep medicine2026Senior author

DOI: 10.1016/j.sleep.2026.108948 PMID: 41946257

Three-order interactions in the alpha band of default mode network EEGs based on O-information rate: insights from aging and Alzheimer's disease.

Azami H, Antonacci Y, Blumberger DM, Brooks H, Faes L, Fischer CE, Flint A, Herrmann N, Kumar S, Gallagher D, Mah L, Mulsant BH, Schoer N, Pollock BG, Rajji TK, PACt-M. D. Study Group

Alzheimer's research & therapy2026

DOI: 10.1186/s13195-026-02131-3 PMID: 42449404

Blood Angiogenesis Markers and Cognition in Older Adults at Risk for Dementia: Marqueurs sanguins de l'angiogenèse et cognition chez les personnes âgées à risque de démence.

Song BX, Vieira E, Gallagher D, Diniz BS, Fischer CE, Flint AJ, Herrmann N, Mah L, Mulsant BH, Rajji TK, Ma C, Lanctôt KL, PACt-MD Study Group

Canadian journal of psychiatry. Revue canadienne de psychiatrie2026

DOI: 10.1177/07067437251337627 PMID: 40304622

Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis.

Gaur A, Wong M, Chen JJ, Kang Y, Tahoulas D, Jeor K, Raguram KH, Gallagher D, Rapoport M, Herrmann N, Lanctôt KL

Alzheimer's & dementia : the journal of the Alzheimer's Association2026

DOI: 10.1002/alz.71501 PMID: 42192211

Frontal white matter hyperintensity burden predicts cognitive response to N-acetylcysteine and exercise in vascular mild cognitive impairment.

Mah E, Gallagher D, Gao F, Ramirez J, Rabin JS, Survilla K, Vieira D, Chen JJ, Kang Y, Andreazza A, Herrmann N, Kiss A, Marzolini S, Oh P, Swardfager W, Black SE, Lanctôt KL

Neurobiology of aging2026

DOI: 10.1016/j.neurobiolaging.2026.01.005 PMID: 41579736

Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial.

Gallagher D, Kang Y, Herrmann N, Kiss A, Black SE, Oh P, Marzolini S, Rabin JS, Andreazza A, Ramirez J, Gao F, Rapoport M, Chen JJ, Survilla K, Vieira D, Mah E, Swardfager W, Lanctôt KL

Alzheimer's research & therapy2026First author

DOI: 10.1186/s13195-026-02062-z PMID: 42045982

Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory post hoc analysis.

Wang HJ, Ruthirakuhan M, Andreazza AC, Beroncal EL, Black SE, Gallagher D, Herrmann N, Kiss A, Verhoeff NPLG, Lanctôt KL

Neurodegenerative disease management2026

DOI: 10.1080/17582024.2025.2587549 PMID: 41220257

Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorder.

Azami H, McAndrews MP, Rostaghi M, Zomorrodi R, Brooks H, Blumberger DM, Fischer CE, Flint A, Herrmann N, Kumar S, Gallagher D, Mah L, Mulsant BH, Pollock BG, Rajji TK, PACt-MD Study Group

Journal of Alzheimer's disease : JAD2026

DOI: 10.1177/13872877251410962 PMID: 41470021

Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial.

Feldman OJ, Herrmann N, Ruthirakuhan M, Gallagher D, L G Verhoeff NP, Kiss A, Black SE, Lanctôt KL

International psychogeriatrics2026

DOI: 10.1016/j.inpsyc.2026.100183 PMID: 41530008

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Alzheimer'S Disease Dear Professor Gallagher, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Angiogenesis markers and cognitive response in a randomized trial of cognitive remediation plus transcranial direct current stimulation in older adults at risk of dementia." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Exercise augmenting cognition tDCS (EXACT) trial: A pilot study of a combined exercise and transcranial direct current stimulation intervention for cognition" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Damien Gallagher

Research

Latest papers

Latest funding

Angiogenesis markers and cognitive response in a randomized trial of cognitive remediation plus transcranial direct current stimulation in older adults at risk of dementia.

Feasibility of home testing to detect undiagnosed obstructive sleep apnea in late life depression.

Three-order interactions in the alpha band of default mode network EEGs based on O-information rate: insights from aging and Alzheimer's disease.

Blood Angiogenesis Markers and Cognition in Older Adults at Risk for Dementia: Marqueurs sanguins de l'angiogen&#xe8;se et cognition chez les personnes &#xe2;g&#xe9;es &#xe0; risque de d&#xe9;mence.

Synaptic biomarkers in Alzheimer's disease dementia and mild cognitive impairment: A systematic review and meta-analysis.

Frontal white matter hyperintensity burden predicts cognitive response to N-acetylcysteine and exercise in vascular mild cognitive impairment.

Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial.

Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory post hoc analysis.

Multiscale dispersion entropy of resting-state EEG in older adults with Alzheimer's disease, mild cognitive impairment, and remitted major depressive disorder.

Assessment of clinical factors that predict response to nabilone for agitation in Alzheimer's disease: A post hoc analysis of a randomized placebo-controlled trial.

Exercise augmenting cognition tDCS (EXACT) trial: A pilot study of a combined exercise and transcranial direct current stimulation intervention for cognition

Pro-Resolving Inflammatory Mediators in Neurovascular Gains in Aerobic Training (PRIMiNG-AT)

Methylphenidate-primed rTMS for apathy in neurocognitive disorders

Understanding the links between depression and increased risk of Alzheimer's dementia: longitudinal analyses of modifiable risks, neuropathology and the role of sex & gender.

Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition

Exercise as a primer for excitatory stimulation study (EXPRESS): A combined exercise and transcranial direct current stimulation intervention for cognition

Efficacy and Safety of N-acetylcysteine (NAC) in patients with mild vascular cognitive impairment

Frequent collaborators

Nathan Herrmann

Susan Marzolini

Sanjeev Kumar

Paul Oh

Walter Swardfager

Myuri Ruthirakuhan

Krista Lanctôt

Mark Rapoport

Alastair Flint

Clement Ma

Erica Vieira

Benoit Mulsant

Ariel Graff-Guerrero

Jocelyn Charles

Zahinoor Ismail

Tarek Rajji

Maged Goubran

Sean Nestor

Mark Sinyor

Arun Seth

Ayal Schaffer

Nicholas Neufeld

Richard Aviv

Katherine Zukotynski

Blood Angiogenesis Markers and Cognition in Older Adults at Risk for Dementia: Marqueurs sanguins de l'angiogenèse et cognition chez les personnes âgées à risque de démence.